The tumor associated antigens that are targeted include surviving, EGFR, VEGFR1 etc. These vaccines could activate local immune cells, releasing tumor antigens, increasing T cells and dendritic cell infiltration to the site of action (58). Here, FLT1 is linked to neoplasm.